GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders

Jan 12, 2018

|

NEW YORK (GenomeWeb) – Genetic disease diagnostics company GeneDx, a subsidiary of Opko's BioReference Laboratories, and the Radboud University Medical Center in the Netherlands are collaborating on research to better understand and manage genetic diseases, Opko Health said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Open Spot

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.

Featured White Papers

For In Vitro Diagnostic Materials: Efficacy vs. Thimerosal and Sodium Azide

Development of a Quantitative Lateral Flow Test Using Estapor Europium Microspheres

Performance of Estapor Microspheres and Hi-Flow Plus Membranes in a Lateral Flow Assay for Human Chorionic Gonadotropin (hCG)

ProClin 300 Preservative An In-depth Technical Analysis

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb

18

Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.

Feb

23

Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Menu

GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders

To read the full story....

Breaking News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Skin Cell Atlas Elucidates Pathological Cell States Underlying Inflammatory Skin Diseases

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

Genetic Technologies to Raise $6.6M in Direct Offering

CareDx Prices $175M Common Stock Offering

The Scan

Open Spot

US to Remain in WHO

Dip Possible

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

Featured White Papers

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

What's Popular?

Lucira Health Files for $115M IPO

Invitae to Raise $400M in Proposed Public Offering

Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents

Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

Sponsorships